Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors

Por Praveen Vikas, Praveen Vikas, Nicholas Borcherding, Nicholas Borcherding, Nicholas Borcherding, Nicholas Borcherding, Adithya Chennamadhavuni, Adithya Chennamadhavuni, Rohan Garje, Rohan Garje
Publicado em 2020-04-01

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma

Por Rohan Garje, Josiah An, Austin Greco, Raju Kumar Vaddepally, Yousef Zakharia
Publicado em 2020-01-01

Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment

Por Rohan Garje, Josiah J. An, Kevin Sanchez, Austin Greco, Jeffrey Stolwijk, Eric Devor, Youcef Rustum, Yousef Zakharia
Publicado em 2018-12-01

Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge

Por Raju Vaddepally, Rajiv Doddamani, Soujanya Sodavarapu, Narasa Raju Madam, Rujuta Katkar, Anupama P. Kutadi, Nibu Mathew, Rohan Garje, Abhinav B. Chandra
Publicado em 2022-03-01

Computerized Decision Support for Bladder Cancer Treatment Response Assessment in CT Urography: Effect on Diagnostic Accuracy in Multi-Institution Multi-Specialty Study

Por Di Sun, Lubomir Hadjiiski, Ajjai Alva, Yousef Zakharia, Monika Joshi, Heang-Ping Chan, Rohan Garje, Lauren Pomerantz, Dean Elhag, Richard H. Cohan, Elaine M. Caoili, Wesley T. Kerr, Kenny H. Cha, Galina Kirova-Nedyalkova, Matthew S. Davenport, Prasad R. Shankar, Isaac R. Francis, Kimberly Shampain, Nathaniel Meyer, Daniel Barkmeier, Sean Woolen, Phillip L. Palmbos, Alon Z. Weizer, Ravi K. Samala, Chuan Zhou, Martha Matuszak
Publicado em 2022-03-01